AdTheorent price target raised to $3 from $2 at Needham

Needham raised the firm’s price target on AdTheorent to $3 from $2 and keeps a Buy rating on the shares after meeting with its CEO Jim Lawson at the 26th Annual Needham Growth Conference. The management’s top goals for 2024 include reporting strong and consistent revenue growth, expanding the Health product platform into new verticals, and continuing rapid adoption and growth of its Health product revenue, the analyst tells investors in a research note. AdTheorent should also benefit from Cookies deprecation because its tech stack uses predictive algorithms to score impressions before its DSP bids on them, the firm added.